Search Clinical Trials
589,776 trials
ID
Status
Phase
Title
Sponsor
NCT07655219
Assessment of the Efficacy of a Highly Standardized Ginger and Perilla Nutraceutical (Dispepril®) in Improving Gastric and Intestinal Symptoms in Patients With Functional DyspepsiaLiaquat University of Medical & Health SciencesNot Yet RecruitingNot Applicable
NCT07655219Not Yet Recruiting
Not Applicable
Assessment of the Efficacy of a Highly Standardized Ginger and Perilla Nutraceut...Liaquat University of Med...
NCT07653165
Use of Hydroprep Wound Therapy With Motion Negative Pressure Therapy for Treatment of Chronic Lower Extremity WoundsWest Boca Center for Wound HealingEnrolling By InvitationNot Applicable
NCT07653165Enrolling By Invitation
Not Applicable
Use of Hydroprep Wound Therapy With Motion Negative Pressure Therapy for Treatme...West Boca Center for Woun...
NCT07652632
Regenerative Endoscopy in Refractory Perianal Crohn's DiseaseAsian Institute of Gastroenterology, IndiaRecruitingNot Applicable
NCT07652632Recruiting
Not Applicable
Regenerative Endoscopy in Refractory Perianal Crohn's DiseaseAsian Institute of Gastro...
NCT07653672
Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe ThrombocytopeniaCentre Hospitalier Annecy GenevoisNot Yet Recruiting
NCT07653672Not Yet Recruiting
—
Role of Viscoelastometric Testing in the Development and Validation of a Clinica...Centre Hospitalier Annecy...
NCT07654465
Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone LymphomaSun Yat-sen UniversityNot Yet RecruitingPhase 2
NCT07654465Not Yet Recruiting
Phase 2
Rituximab Maintenance Versus Observation After R2 Induction in Previously Untrea...Sun Yat-sen University
NCT07652476
Neurocognitive Assessment in Long-Term Survivors of LymphomaAssociazione Italiana contro Leucemie, Linfomi e MielomaNot Yet Recruiting
NCT07652476Not Yet Recruiting
—
Neurocognitive Assessment in Long-Term Survivors of LymphomaAssociazione Italiana con...
NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsNot Yet RecruitingPhase 3
NCT07654374Not Yet Recruiting
Phase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes...Gasherbrum Bio, Inc., a w...
NCT07652346
The Impact of Qualia Vitamin C+ on Individuals With Suboptimal and Adequate Vitamin C LevelsQualia Life SciencesNot Yet RecruitingNot Applicable
NCT07652346Not Yet Recruiting
Not Applicable
The Impact of Qualia Vitamin C+ on Individuals With Suboptimal and Adequate Vita...Qualia Life Sciences
NCT07652762
IN10018 in Combination With Dalpiciclib for Progressive MeningiomasCapital Medical UniversityNot Yet RecruitingPhase 1
NCT07652762Not Yet Recruiting
Phase 1
IN10018 in Combination With Dalpiciclib for Progressive MeningiomasCapital Medical Universit...
NCT07652437
Study of Wearable Interventions for Improving Mobility of Individuals With Knee OsteoarthritisMassachusetts Institute of TechnologyRecruitingNot Applicable
NCT07652437Recruiting
Not Applicable
Study of Wearable Interventions for Improving Mobility of Individuals With Knee...Massachusetts Institute o...
NCT07654608
Electromyographic Response to Blood Flow Restriction Exercise in Healthy AdultsUniversidad de ExtremaduraCompletedNot Applicable
NCT07654608Completed
Not Applicable
Electromyographic Response to Blood Flow Restriction Exercise in Healthy AdultsUniversidad de Extremadur...
NCT07654231
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD: A Pilot Randomized Open-Label TrialUniversity of Texas Southwestern Medical CenterNot Yet RecruitingPhase 2
NCT07654231Not Yet Recruiting
Phase 2
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchi...University of Texas South...
NCT07655115
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With thFundación para la Investigación Biomédica del Hospital Gregorio MaranonRecruitingPhase 3
NCT07655115Recruiting
Phase 3
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability...Fundación para la Investi...
NCT07654985
Probiotic Yogurt in Patients With Chronic CholecystitisLanZhou UniversityNot Yet RecruitingNot Applicable
NCT07654985Not Yet Recruiting
Not Applicable
Probiotic Yogurt in Patients With Chronic CholecystitisLanZhou University
NCT07652840
Treatment Adherence Among Patients With Inflammatory Bowel Disease Receiving Anti-TNF TherapyIzmir Katip Celebi UniversityCompletedNot Applicable
NCT07652840Completed
Not Applicable
Treatment Adherence Among Patients With Inflammatory Bowel Disease Receiving Ant...Izmir Katip Celebi Univer...
NCT07652255
Subgingival Lactobacillus Reuteri as an Adjunct to Non-Surgical Periodontal Therapy in Diabetic PatientsUniversity of Medicine and Pharmacy at Ho Chi Minh CityCompletedNot Applicable
NCT07652255Completed
Not Applicable
Subgingival Lactobacillus Reuteri as an Adjunct to Non-Surgical Periodontal Ther...University of Medicine an...
NCT07654036
Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung CancerPeking University People's HospitalEnrolling By InvitationNot Applicable
NCT07654036Enrolling By Invitation
Not Applicable
Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical...Peking University People'...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting4 (20%)
Completed3 (15%)
Enrolling by invitation2 (10%)
Unknown1 (5%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 22 (10%)
Phase 32 (10%)
Phase 12 (10%)